§ 01 Overview
Overview
Oral capsule form of BPC-157, targeting gut healing where local action is desirable.
Oral dosing studied in rats for GI indications. No human trials.
§ 02 Mechanism
Mechanism of action
BPC-157 is naturally derived from a stable gastric protein and is thought to retain activity in the GI tract. Oral administration is particularly suited for gut-localized effects on the mucosa.
- 01Localized gut healing support
- 02Convenience over injections for GI indications
§ 03 Dosing
Dosing protocol
Standard Protocol
- Dose Range
- 500 mcg 1–2x daily
- Route
- Oral
- Frequency
- Daily
- Cycle
- 4–8 weeks
§ 04 Evidence
Evidence & research
Oral dosing studied in rats for GI indications. No human trials.
FDA Status
Not FDA-approved. On FDA 503A Negative List.
§ 05 Stacks
Common stacks
§ 06 News
In the news
5 articles from the last 12 months · updates hourly
bpc 157 tendinitis BPC-157 gets talked about like it is a proven fix for muscle tears, tendons, ligaments, and chronic joint pain. The reality is different. The latest 2025 systematic review shows that every strong - news36live
bpc 157 tendinitis BPC-157 gets talked about like it is a proven fix for muscle tears, tendons, ligaments, and chronic joint pain. The reality is different. The latest 2025 systematic review shows that every strong news36live
topical bpc 157 reddit Once people understood glucagonlike peptide 1 (GLP-1) drugs' potential for weight loss, the race among pharmaceutical companies was on. Among the current options, Wegovy can help people lose an average of 10 - news36live
topical bpc 157 reddit Once people understood glucagonlike peptide 1 (GLP-1) drugs' potential for weight loss, the race among pharmaceutical companies was on. Among the current options, Wegovy can help people lose an average of 10 news36live
BPC-157 Erectile Dysfunction Study: What the Current Evidence Shows - Portal CNJ
BPC-157 Erectile Dysfunction Study: What the Current Evidence Shows Portal CNJ
RFK Jr. may make it easier to get peptides — but what do doctors think? - New York Post
RFK Jr. may make it easier to get peptides — but what do doctors think? New York Post
ProHealth BPC-157 Review 2026: Don't Buy Peptide Supplements Without Reading This First! - ACCESS Newswire
ProHealth BPC-157 Review 2026: Don't Buy Peptide Supplements Without Reading This First! ACCESS Newswire
§ 07 Sourcing
Sourcing & supply
Regulatory status
Restricted from compounding
Placed on the FDA's 503A Category 2 list and cannot be lawfully compounded in the US. No brand pharmacy alternative exists. US buyers encounter only research-use-only (RUO) channels, which the FDA's Intended Use Doctrine treats as unapproved drug sales.
No suppliers in our directory currently stock this compound. For investigational or research-only compounds, legitimate channels may not exist outside clinical trials.
Browse full supplier directory§ 09 Safety
Safety & side effects
Side effects
- 01Generally well tolerated
Contraindications
None specified.
§ 10 Questions
BPC-157 (Capsules) FAQ
- What is BPC-157 (Capsules)?
- Oral capsule form of BPC-157, targeting gut healing where local action is desirable. BPC-157 is naturally derived from a stable gastric protein and is thought to retain activity in the GI tract. Oral administration is particularly suited for gut-localized effects on the mucosa.
- What is BPC-157 (Capsules) used for?
- Reported uses include localized gut healing support and convenience over injections for gi indications. Evidence strength is rated Preclinical — see the evidence section for detail.
- How is BPC-157 (Capsules) dosed?
- Commonly referenced dosing is 500 mcg 1–2x daily, administered Oral. This is educational reference only; consult a licensed clinician before use.
- What are the side effects of BPC-157 (Capsules)?
- Commonly reported side effects include generally well tolerated. This list is not exhaustive.
- Is BPC-157 (Capsules) legal?
- Placed on the FDA's 503A Category 2 list and cannot be lawfully compounded in the US. No brand pharmacy alternative exists. US buyers encounter only research-use-only (RUO) channels, which the FDA's Intended Use Doctrine treats as unapproved drug sales. FDA status: Not FDA-approved. On FDA 503A Negative List..